Nard,Aveecia ink tech deal

摘要

Japan's nard Institute has signed a technology-transfer agreement with Avecia Pharmaceuticals,ACN was told.Nard's director of life science-relatedbusiness development,Masaaki Matsuo,said the agreement provided for the transfer of key Avecia technologies for the transfer of key Avecia technologies for the production of catalystsfor chiral manufacturing,enzymatic bio-transformations,and the production of encapsulatedpalladium catalysts for faster and cleaner drug development.